# Bioavailability of Duloxetine 60 mg With Regards to Reference Product in Fasting Conditions

> **NCT04723238** · PHASE1 · COMPLETED · sponsor: **Laboratorios Andromaco S.A.** · enrollment: 36 (actual)

## Conditions studied

- Bioequivalence

## Interventions

- **DRUG:** Duloxetine 60mg Test Drug Enteric Coated Granules
- **DRUG:** Duloxetine 60mg Reference Product Enteric Coated Granules

## Key facts

- **NCT ID:** NCT04723238
- **Lead sponsor:** Laboratorios Andromaco S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-23
- **Primary completion:** 2021-02-09
- **Final completion:** 2021-03-26
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2021-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04723238

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04723238, "Bioavailability of Duloxetine 60 mg With Regards to Reference Product in Fasting Conditions". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT04723238. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*